CP 316819 (Synonyms: GPi 819) |
| Katalog-Nr.GC15877 |
CP 316819 ist ein potenter Glykogen-Phosphorylase (GPase)-Inhibitor mit antihyperglykämischer Wirkung (IC50-Werte sind 17 und 34 nM gegen humane Skelettmuskel-Glykogen-Phosphorylase (huSMGPa) bzw. Leber-Glykogen-Phosphorylase (huLGPa)).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 186392-43-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for CP 316819
Average Rating: 5 (Based on Reviews and 17 reference(s) in Google Scholar.)
Review for CP 316819
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *